7580 people witnessed adverse reactions across India in first phase: Govt


Hyderabad: A total of 7580 people witnessed Adverse Event Following Immunization (AEFI) till January 31.Twelve people have died. However, the government has categorically mentioned that the deaths are not causally related to vaccination. "These deaths were investigated and examined by the experts and as per current evidence, none of these deaths have a causal relationship with the COVID-19 vaccination. In addition, measures have been put in place like availability of anaphylaxis kits at each vaccination site, immediate referral to AEFI management center and observation of vaccine recipients for 30 minutes at session site for any adverse events so as to take timely corrective measure" said Harsh Vardhan-Minister of Health and family welfare.

India's Central Drugs Standards Control Organization (CDSCO) has granted permission to manufacture both Covishield and Covaxin as per New Drugs and Clinical Trials Rules, 2019. Currently, these two vaccinations have been rolled out.